1. Adan RAH, Tiesjema B, Hillebrand JJG, La Fleur SE, Kas MJH, de Krom M (2006) The MC4 receptor and control of appetite. Br J Pharmacol 149:815–827. https://doi.org/10.1038/sj.bjp.0706929
2. Anon (2000) ICHS7A: safety pharmacology studies for human pharmaceuticals. CPMP/ICH/539/00. London. https://database.ich.org/sites/default/files/S7A_Guideline.pdf
3. Anon (2005) ICHS7B: the nonclinical evaluation of the potential for delayed repolarisation (QT interval prolongation) by human pharmaceuticals. https://database.ich.org/sites/default/files/S7B_Guideline.pdf
4. Anon (2022) ICH E14/S7B implementation working group clinical and nonclinical evaluation of QT/QTc interval prolongation and proarrhythmia potential. Questions and answers. https://database.ich.org/sites/default/files/E14-S7B_QAs_Step4_2022_0221.pdf
5. Anon. CreibleMeds. https://crediblemeds.org